Marko Mihelic

Title: Marko Mihelic: Innovator in Biochemistry

Introduction

Marko Mihelic is a notable inventor based in Slovenia. He has made significant contributions to the field of biochemistry, particularly in the study of Staphylococcus aureus autolysin E. His work focuses on understanding the crystal structure of this enzyme, which has implications for medical research and drug development.

Latest Patents

Marko Mihelic holds a patent titled "Crystal Structure Of Staphylococcus Aureus Autolysin E, Method Of Producing The Crystal And Its Use In Screening Methods." This invention involves the determination and evaluation of the crystal structure of autolysin E (AtlE) of Staphylococcus aureus, or a crystallizable fragment of AtlE. The patent outlines a method for producing a crystal of AtlE and the respective crystallization kit. It also details its use in screening methods to identify inhibitors of the N-acetylglucosaminidase activity of AtlE, which is crucial for obtaining atomic spatial relationship data and identifying binding compounds through in silico screening.

Career Highlights

Marko Mihelic is affiliated with the J. Stefan Institute, where he conducts his research. His work has been instrumental in advancing the understanding of bacterial enzymes and their potential applications in medicine. Despite having no patents listed under his name, his contributions to the field are noteworthy.

Collaborations

Throughout his career, Marko has collaborated with esteemed colleagues such as Miha Renko and Dusan Turk. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Marko Mihelic is a dedicated inventor whose research on Staphylococcus aureus autolysin E has the potential to influence future medical advancements. His work exemplifies the importance of innovation in the field of biochemistry.